home / stock / eyeg / eyeg news

EYEG News and Press, Eyegate Pharmaceuticals Inc. From 09/09/21

Stock Information
Company Name: Eyegate Pharmaceuticals Inc.
Stock Symbol: EYEG
Market: NASDAQ
Menu
EYEG EYEG Quote EYEG Short EYEG News EYEG Articles EYEG Message Board
Get EYEG Alerts

News, Short Squeeze, Breakout and More Instantly...
EYEG - EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage specialty pharmaceutical company developing and commercializing products for treating ophthalmic diseases, today a...
EYEG - EyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for the Treatment of Ocular Surface Inflammation

-Proof-of-concept study conducted in Austria; Study designed to build upon positive Phase 1 safety data in healthy volunteers- -Trial remains on track with topline data expected in Q4 2021- WALTHAM, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) --  EyeGate Pharmaceuticals, I...

EYEG - Top Penny Stocks You Need to Know About Right Now

4 Top Penny Stocks to Watch as August Comes to an End With the end of August in sight, many investors are looking for the best penny stocks to buy. But, it’s not as simple as a quick Google search, rather, investors need to spend time researching every penny stock on their list. ...

EYEG - EyeGate Pharma Reports Second Quarter 2021 Financial Results and Provides Business Update

WALTHAM, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye an...
EYEG - EyeGate Announces Closing of $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

WALTHAM, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or the “Company”), a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and...

EYEG - AHPI, MDIA, SCPE among mid-day movers

Gainers: Fulcrum Therapeutics (NASDAQ:FULC) +123%. Lightning eMotors (NYSE:ZEV) +52%. 3D Systems (NYSE:DDD) +41%. MediaCo (NASDAQ:MDIA) +40%. Allied Healthcare Products (NASDAQ:AHPI) +27%. Exagen (NASDAQ:XGN) +26%. IMV (NASDAQ:IMV) +23%. Arcturus Therapeutics (NASDAQ:ARCT) +21%. Orphazyme A/S...

EYEG - Fulcrum Therapeutics, Allied Healthcare Products leads healthcare gainers; SmileDirectClub, EyeGate Pharmaceuticals among major losers

Gainers: Fulcrum Therapeutics (NASDAQ:FULC) +84%, Allied Healthcare Products (NASDAQ:AHPI) +39%, IMV (NASDAQ:IMV) +29%, Exagen (NASDAQ:XGN) +26%, Myomo (NYSE:MYO) +22%. Losers: SmileDirectClub (NASDAQ:SDC) -23%, EyeGate Pharmaceutica...
EYEG - EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

WALTHAM, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or the “Company”), a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and...

EYEG - Akamai Technologies, Healthcare Trust of America, Change Healthcare among premarket losers' pack

Zymergen (NASDAQ:ZY) -74% after forecasting no revenues this year, CEO exits Flora Growth (NASDAQ:FLGC) -15%. Tellurian (NASDAQ:TELL) -12% on Q2 earnings release and to offer shares; size not determined. LivePerson (NASDAQ:LPSN) -10% on Q2 earnings release. ...

EYEG - CAN, DAO, NEGG among mid-day movers

Gainers: Bit Digital (BTBT) +51%.Infinity Pharmaceuticals (INFI) +46%.NanoVibronix (NAOV) +40%.Tilray (TLRY) +26%.Flora Growth Corp. (FLGC) +25%.Youdao (DAO) +24%.Grove (GRVI) +22%.Zhangmen Education (ZME) +23%.First High-School Education (FHS) +22%.Canaan (CAN) +21%.Losers: Hoegh LNG Partner...
Previous 10 Next 10